Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Stephanie Born"'
Autor:
Aly Matejka, Stephanie Born
Publikováno v:
Journal of Sports Medicine and Allied Health Sciences: Official Journal of the Ohio Athletic Trainers' Association, Vol 8, Iss 1 (2022)
OBJECTIVE: A survey was created to assess the experience, education, and self-perceived competence of treating and/or training pregnant and postpartum athletes among athletic trainers, strength coaches, and coaches.
Externí odkaz:
https://doaj.org/article/483e55dd4fcb4cc8ab010e39b1e77212
Autor:
Lisa M. Plitnick, Beth Hutchins, Sheri Dubey, Nianyu Li, Rupesh P. Amin, Stephanie Born, Ruban Mangadu, Joseph H. Phillips, Venkataraman Sriram, Danuta J. Herzyk
Publikováno v:
Journal of Immunotoxicology, Vol 17, Iss 1, Pp 175-185 (2020)
The programmed cell death 1 (PD-1) pathway represents a major immune checkpoint which may be engaged by cells in a tumor microenvironment to overcome active T-cell immune surveillance. Pembrolizumab (Keytruda®) is a potent and highly selective human
Externí odkaz:
https://doaj.org/article/2b47def718a34f4fad7a7bc77b84c7e9
Autor:
Stephanie Born, Yi-Zhong Gu, Larry Handt, Vasudevan Bakthavatchalu, Katerina Vlasakova, Frank D. Sistare, Guillermo Fernandez, Warren E. Glaab, Roger Smith
Publikováno v:
Toxicologic Pathology. 50:35-46
Kidney biopsies are used sparingly to diagnose kidney injury in the clinic. Here we have conducted a small exploratory study to directly compare the low-grade kidney injury monitoring performance of serum safety biomarkers, novel urine safety biomark
Autor:
Stephanie Born, Lisa M. Plitnick, Ruban Mangadu, Danuta J. Herzyk, Venkataraman Sriram, Sheri Dubey, Joseph H. Phillips, Beth Hutchins, Rupesh P. Amin, Nianyu Li
Publikováno v:
Journal of Immunotoxicology, Vol 17, Iss 1, Pp 175-185 (2020)
The programmed cell death 1 (PD-1) pathway represents a major immune checkpoint which may be engaged by cells in a tumor microenvironment to overcome active T-cell immune surveillance. Pembrolizumab (Keytruda®) is a potent and highly selective human
Publikováno v:
Regulatory Toxicology and Pharmacology. 86:181-192
Suvorexant (Belsomra®) is a dual orexin receptor antagonist approved for the treatment of insomnia. Because of its pharmacology within the central nervous system, intended therapeutic indication, and first-in-class status, an assessment of suvorexan
Autor:
Karen Tse, Esther Rodriguez Villegas, Samuel J. Jackson, Aileen Milne, Helen Prior, Karlijn Wilschut, Stephanie Born, Richard Briscoe
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 105:106708
Publikováno v:
Drug Metabolizing Enzymes ISBN: 9780824742935
Drug Metabolizing Enzymes
Drug Metabolizing Enzymes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74bea9b1299c9900e5af002c933e1978
https://doi.org/10.1201/9781420028485.ch6
https://doi.org/10.1201/9781420028485.ch6
Autor:
Ostalska, Katarzyna1 katarzyna.ostalska@uni.lodz.pl
Publikováno v:
Text Matters. 2023, Issue 13, p275-297. 23p.
Publikováno v:
Ohio Journal of Science. 2022, Vol. 122 Issue 1, p8-16. 9p.
Autor:
Plitnick, Lisa M.1 (AUTHOR), Hutchins, Beth1 (AUTHOR), Dubey, Sheri1 (AUTHOR), Li, Nianyu1 (AUTHOR), Amin, Rupesh P.1 (AUTHOR), Born, Stephanie1 (AUTHOR), Mangadu, Ruban1 (AUTHOR), Phillips, Joseph H.1 (AUTHOR), Sriram, Venkataraman1 (AUTHOR), Herzyk, Danuta J.1 (AUTHOR)
Publikováno v:
Journal of Immunotoxicology. Dec2020, Vol. 17 Issue 1, p175-185. 11p.